170 related articles for article (PubMed ID: 37795393)
1. Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocol.
McClelland S; Sun Y; Spratt DE
Rep Pract Oncol Radiother; 2023; 28(3):379-388. PubMed ID: 37795393
[TBL] [Abstract][Full Text] [Related]
2. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
3. Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases.
Ekpunobi IO; McClelland S
Am J Clin Oncol; 2024 Jun; 47(6):289-290. PubMed ID: 38372269
[TBL] [Abstract][Full Text] [Related]
4. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
[TBL] [Abstract][Full Text] [Related]
6. Vertebral body fracture rates after stereotactic body radiation therapy compared with external-beam radiation therapy for metastatic spine tumors.
Vargas E; Susko MS; Mummaneni PV; Braunstein SE; Chou D
J Neurosurg Spine; 2020 Aug; 33(6):870-876. PubMed ID: 32796141
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Patterns of Conventional Versus Stereotactic Body Radiotherapy in the Treatment of Spine Metastasis in the United States.
Kim E; McClelland S; Jaboin JJ; Attia A
J Palliat Care; 2021 Apr; 36(2):130-134. PubMed ID: 33356987
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
10. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.
Nguyen QN; Chun SG; Chow E; Komaki R; Liao Z; Zacharia R; Szeto BK; Welsh JW; Hahn SM; Fuller CD; Moon BS; Bird JE; Satcher R; Lin PP; Jeter M; O'Reilly MS; Lewis VO
JAMA Oncol; 2019 Jun; 5(6):872-878. PubMed ID: 31021390
[TBL] [Abstract][Full Text] [Related]
11. Spine stereotactic radiosurgery for the treatment of multiple myeloma.
Miller JA; Balagamwala EH; Chao ST; Emch T; Suh JH; Djemil T; Angelov L
J Neurosurg Spine; 2017 Mar; 26(3):282-290. PubMed ID: 27791828
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Treatment Strategies for Spinal Metastases.
Kowalchuk RO; Mullikin TC; Kim DK; Morris JM; Ebner DK; Harmsen WS; Merrell KW; Beriwal S; Waddle MR; Kim H
Pract Radiat Oncol; 2022; 12(3):236-244. PubMed ID: 35045365
[TBL] [Abstract][Full Text] [Related]
13. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
15. Response assessment after stereotactic body radiation therapy for spine and non-spine bone metastases: results from a single institutional study.
Correia D; Moullet B; Cullmann J; Heiss R; Ermiş E; Aebersold DM; Hemmatazad H
Radiat Oncol; 2022 Feb; 17(1):37. PubMed ID: 35189919
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806).
Isfahanian N; Lukka H; Dayes I; Quan K; Schnarr KL; Douvi G; Goldberg M; Wright J; Swaminath A; Chow T; Diamond K; Cutz JC; Kavsak P; Thabane L; Tsakiridis T
Clin Genitourin Cancer; 2020 Aug; 18(4):e410-e415. PubMed ID: 32265129
[TBL] [Abstract][Full Text] [Related]
17. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for osseous low alpha-beta resistant metastases for pain relief-SOLAR-P.
Nguyen EK; Quan K; Parpia S; Tran S; Swaminath A
Radiat Oncol; 2021 Sep; 16(1):170. PubMed ID: 34479581
[TBL] [Abstract][Full Text] [Related]
19. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
[TBL] [Abstract][Full Text] [Related]
20. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
